-
Many of the generic manufacturers started years back with knock off drugs to sell locally in India, but now the game is changing to where US Pharma is using some of the talent, which costs less than R and D individuals here in the states, to further develop existing work, in other words somewhat continue...
-
This is not the first time this issue has been in the news in the last couple of years, but the dollars, or lack of dollars perhaps bring this to light once more, and once more it all comes back to money. There are some interesting efforts going on to try and combat the problem, such as Aetna paying...
-
The battle continues on but once the FDA opens offices in India, perhaps that will help out being close to the source to ensure safety and compliance. Meanwhile Ranbaxy is business as usual with continuing to submit new drugs and information to the FDA, and they are the 15th largest producer of...
-
More information can be found here. October is breast cancer awareness month. As of today, the site states information is coming soon so check back for any new announcements. You will need to participate in the Curves coaching program for exercise if not already enrolled. Current...
-
Yes you heard it right, there's an online advertising spot that will grant access to the game, you can perhaps find it on Forbes and other online publications, and you also get to listen to "Viva Viagra" while you play. So who's next in the Pharma game advertising loop? ...
-
This goes back to everyone is in control, yet nobody is in control. The one statement below says it all, technology is out of control, and this is just one example. Do we really know if we are consuming products from cloned animals? Can the FDA tell us this safe? Nobody has the...
-
A picture is worth 1000 words. I have recently had some conversations with health care clinicians, administrators, etc. about the Personal health records of Google and Microsoft Health Vault and this shows clearly how Beth Israel Deaconess has integrated the system with their own internal system...
-
One cancer drug turned down after many years of research, but the company plans an appeal. The FDA continues to ask for substantial documentation in the hopes of better decision. Refusals don't help the cause when it comes to investors and the potential for continued research. Something...
-
More big fish, small fish in the Pharma business, this time a 3rd Japanese firm buying a US Company. Are there going to be many left here in the US, Pfizer we love you. BD Shionogi, is buying Sciele Pharma, a small, publicly traded drug maker based in Atlanta. The all-cash deal is...
-
With all the focus on cancer of late, which is of course very important, it's nice to see some other research and good clinical results for other chronic conditions, such as Gout. I have watch my mother, who is 84 years old, and who is also a diabetic who has gout, for years, trying to balance...